Ciliary Neurotrophic Factor (human)
Ciliary Neurotrophic Factor (human) Uses, Dosage, Side Effects, Food Interaction and all others data.
Ciliary Neurotrophic Factor (human) (NT-501) is Neurotech's lead product which is in two Phase II/III clinical trials for the treatment of visual loss associated with retinitis pigmentosa and a Phase II trial for the treatment of the dry form of age-related macular degeneration. Neurotech is also evaluating other factors that can be used with its proprietary delivery technology, Encapsulated Cell Technology (ECT), to treat additional retinal diseases.
| Trade Name | Ciliary Neurotrophic Factor (human) |
| Generic | Ciliary neurotrophic factor |
| Ciliary neurotrophic factor Other Names | Ciliary neurotrophic factor (human), Human ciliary neurotrophic factor, Human CNTF |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Uses
Investigated for use/treatment in eye disorders/infections, macular degeneration, and retinal disorders (unspecified).
How Ciliary Neurotrophic Factor (human) works
NT-501 is an intraocular, cell containing polymer implant designed to provide the continuous, long-term release of the therapeutic protein, Ciliary Neurotrophic Factor (CNTF), directly into the back of the eye by means of the Company's proprietary Encapsulated Cell Technology (ECT).
Innovators Monograph
You find simplified version here Ciliary Neurotrophic Factor (human)
